The Expressions of Serum β2-MG, HGF and TGFβ1 in Patients with Acute Myeloid Leukemia and Their Clinical Significances

doi:10.11748/bjmy.issn.1006-1703.2020.03.029

PDF(3552 KB)

Labeled Immunoassays and Clinical Medicine ›› 2020, Vol. 27 ›› Issue (3) : 488-492. DOI: 10.11748/bjmy.issn.1006-1703.2020.03.029

The Expressions of Serum β2-MG, HGF and TGFβ1 in Patients with Acute Myeloid Leukemia and Their Clinical Significances

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2020, 27(3): 488-492 https://doi.org/10.11748/bjmy.issn.1006-1703.2020.03.029

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(3552 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Revised	Published
2019-11-28	2020-01-20	2020-03-20
Issue Date
2020-08-18

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS